Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Sep 2021 – 20 Aug 2026, limited by Axis Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Value Fund | Nifty 500 |
|---|---|---|
| 28 Sep 2021 | ₹100.00 | ₹100.00 |
| 24 Feb 2022 | ₹93.40 | ₹91.26 |
| 23 Jul 2022 | ₹98.10 | ₹94.97 |
| 19 Dec 2022 | ₹106.70 | ₹104.37 |
| 17 May 2023 | ₹110.40 | ₹102.19 |
| 13 Oct 2023 | ₹130.60 | ₹115.20 |
| 10 Mar 2024 | ₹158.50 | ₹135.37 |
| 05 Aug 2024 | ₹183.70 | ₹149.33 |
| 01 Jan 2025 | ₹193.70 | ₹148.22 |
| 30 May 2025 | ₹174.30 | ₹151.05 |
| 26 Oct 2025 | ₹185.50 | ₹156.91 |
| 24 Mar 2026 | ₹156.90 | ₹139.56 |
| 20 Aug 2026 | ₹183.40 | ₹155.76 |
| Metric | Axis · Direct · IDCW NAV ₹18.34 Very High risk ★★★★☆ | Category median Value Fund · 27 funds |
|---|---|---|
| +2.34% | +2.79% | |
| +13.75% | +12.68% | |
| — | +11.98% | |
| — | +10.69% | |
| +13.20% | +11.75% | |
| +12.59% | — | |
| +19.25% | +13.57% | |
| — | +12.46% | |
| — | +12.08% | |
| Risk | ||
| 15.64% | 14.87% | |
| 0.46 | 0.40 | |
| 0.58 | 0.54 | |
| -24.02% | -37.93% | |
| Nifty 500 | — | |
| +1.31% | +0.85% | |
| 1.06 | 0.95 | |
| 117.7% | 102.9% | |
| 122.0% | 102.9% | |
| 0.99% | 1.20% | |
| ₹1,552Cr | ₹1,405Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 45% | 40% | |
| Krishnaa Narayan | — | |
| 28 Sep 2021 | — | |
| 87 | — | |
| 33.1% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.